Sign Up to like & get
recommendations!
3
Published in 2022 at "Biotechnology advances"
DOI: 10.1016/j.biotechadv.2022.107917
Abstract: Chimeric antigen receptor (CAR) technology, and CAR-T cells in particular, have emerged as a new and powerful tool in cancer immunotherapy since demonstrating efficacy against several hematological malignancies. However, despite encouraging clinical results of CAR-T…
read more here.
Keywords:
cell therapies;
car engineered;
novel car;
engineered cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Hematology/oncology and stem cell therapy"
DOI: 10.56875/2589-0646.1048
Abstract: Increasing success of adaptive cell therapy (ACT), such as genetically engineered T cells to express chimeric antigen receptors (CARs) proven to be highly significant technological advancements and impressive clinical outcomes in selected haematological malignancies, with…
read more here.
Keywords:
engineered cells;
car;
car engineered;
clinical grade ... See more keywords